Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

The Changing Face of GI Endoscopy

Executive Summary

The medical device market for gastrointestinal diseases is significant, particularly the GI endoscopy product segment. As the second largest segment of the worldwide endoscopy market, GI endoscopy product sales were more than $1.4 billion in 2004 and are projected to reach more than $3 billion by 2010. Advances in GI diagnostics and screening technologies are helping to drive this market, including new endoscopic technologies designed to improve diagnostic sensitivity, patient comfort, and procedural efficiency.

You may also be interested in...



Crospon Ltd.

New imaging technology employed through a therapeutic endoscope provides the most relevant information to diagnose gastroesophageal reflux disease (GERD), according to its manufacturer, Crospon. Furthermore, the Irish start-up says its novel EndoFLIP (endoscopic functional lumen imaging probe) technology can be used to assist in GERD surgeries and to assess the results.

Business & Technology Briefs (10/2007)

New spine company Globus raises $110 million from Clarus Ventures; Medco Health Solutions acquires PolyMedica Corp. for $1.5 billion; Olympus' long-awaited capsule endoscope receives US regulatory clearance; Concentric Medical launches another iteration of its Merci Retriever for ischemic stroke.

Business & Technology Briefs (10/2007)

New spine company Globus raises $110 million from Clarus Ventures; Medco Health Solutions acquires PolyMedica Corp. for $1.5 billion; Olympus' long-awaited capsule endoscope receives US regulatory clearance; Concentric Medical launches another iteration of its Merci Retriever for ischemic stroke.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel